# Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets

> **NCT00343278** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 18 (—)

## Conditions studied

- Virus Diseases

## Interventions

- **DRUG:** Valaciclovir Hydrochloride

## Key facts

- **NCT ID:** NCT00343278
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 18 (—)
- **Last updated:** 2015-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00343278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00343278, "Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00343278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*